Background: Laser ablation may be useful in debulking of benign thyroid nodules. Methods: To evaluate retrospectively the effectiveness and safety of LA, 45 patients with benign solid thyroid nodules, with a fluid component ≤20%, were included in our series between October 2009 and January 2011. All reported pressure and/or cosmetic complaints. Nd:YAG laser at 1064 nm was used, with a fix-power (3W), changing the application time. All patients were evaluated at baseline, 6 and 12 months. Complications were recorded. Results: mean nodule volume reduction decreased from 24.2 mL ±19.4 to 4.5 ± 5.2 at 12 months (p<0.001). Mean nodule volume reduction was 84% ± 13. Cosmetic signs were completely resolved in 87%, reduced in 9%, unchanged in 2%; pressure symptoms were resolved in 88%. One patient experienced transient dysphonia. Conclusions: US-guided LA is an effective tool for treatment of symptomatic benign thyroid nodules in patients not eligible for surgery. This article is protected by copyright. All rights reserved.

Achille, G., Zizzi, S., Di Stasio, E., Grammatica, A., Grammatica, L., Ultrasound-guided percutaneous laser ablation (LA) in treating symptomatic solid benign thyroid nodules: Our experience in 45 patients, <<HEAD & NECK>>, 2016; 38 (5): 677-682. [doi:10.1002/hed.23957] [http://hdl.handle.net/10807/64741]

Ultrasound-guided percutaneous laser ablation (LA) in treating symptomatic solid benign thyroid nodules: Our experience in 45 patients

Di Stasio, Enrico;
2016

Abstract

Background: Laser ablation may be useful in debulking of benign thyroid nodules. Methods: To evaluate retrospectively the effectiveness and safety of LA, 45 patients with benign solid thyroid nodules, with a fluid component ≤20%, were included in our series between October 2009 and January 2011. All reported pressure and/or cosmetic complaints. Nd:YAG laser at 1064 nm was used, with a fix-power (3W), changing the application time. All patients were evaluated at baseline, 6 and 12 months. Complications were recorded. Results: mean nodule volume reduction decreased from 24.2 mL ±19.4 to 4.5 ± 5.2 at 12 months (p<0.001). Mean nodule volume reduction was 84% ± 13. Cosmetic signs were completely resolved in 87%, reduced in 9%, unchanged in 2%; pressure symptoms were resolved in 88%. One patient experienced transient dysphonia. Conclusions: US-guided LA is an effective tool for treatment of symptomatic benign thyroid nodules in patients not eligible for surgery. This article is protected by copyright. All rights reserved.
2016
Inglese
Achille, G., Zizzi, S., Di Stasio, E., Grammatica, A., Grammatica, L., Ultrasound-guided percutaneous laser ablation (LA) in treating symptomatic solid benign thyroid nodules: Our experience in 45 patients, <<HEAD & NECK>>, 2016; 38 (5): 677-682. [doi:10.1002/hed.23957] [http://hdl.handle.net/10807/64741]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/64741
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 35
social impact